MedTrace Logo

ExoDx Prostate Evaluation in Active Surveillance Patient Population

NCT05572099 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2022-10-07

No results posted yet for this study

Summary

The goal of this observational study is to test whether the ExoDx Prostate test add value in biopsy decision making to patients with prostate cancer on an active surveillance regimen.

Conditions

Interventions

DIAGNOSTIC_TEST

ExoDx Prostate

Observational only.

Sponsors & Collaborators

  • Exosome Diagnostics, Inc.

    lead INDUSTRY

Principal Investigators

  • Sonia Kumar, PhD · Exosome Diagnostics, Inc.

Eligibility

Min Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2023-10-31
Completion
2023-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05572099 on ClinicalTrials.gov